Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Mach7 Technologies Ltd. ( (AU:M7T) ) is now available.
Mach7 Technologies is set to announce its H1 FY25 financial results on 27 February 2025 and will host a webinar for investors featuring CEO Mike Lampron and CFO Dyan O’Herne. The results release and subsequent investor webinar provide an opportunity for stakeholders to gain insights into the company’s operational performance and strategic direction.
More about Mach7 Technologies Ltd.
Mach7 Technologies, established in 2007, is a provider of medical imaging systems that offer innovative image management and viewing solutions for healthcare organizations. Their flagship offering, the Mach7 Enterprise Imaging Solution, includes Enterprise Data Management, Enterprise Diagnostic Viewing, and Departmental Workflow applications. With solutions that can be deployed either on a component basis or as a unified platform, the company serves over 165 customers across 15 countries, including integrated delivery networks, national health systems, and academic medical institutions.
YTD Price Performance: 0.0%
Average Trading Volume: 4,072
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.92M
See more insights into M7T stock on TipRanks’ Stock Analysis page.
